Baclofen

Baclofen is a centrally acting muscle relaxant that works as an agonist at GABA-B receptors. It has been used for decades to calm spasticity in conditions such as multiple sclerosis and spinal cord injury, which is what its FDA approval covers. In a neuro-ophthalmology clinic it earns its place for a narrower and more specific reason: it is the most dependable oral medication for periodic alternating nystagmus, an involuntary eye oscillation that slowly reverses direction every couple of minutes. Its use for nystagmus and for facial spasm disorders is off-label, meaning the drug is prescribed based on clinical evidence and experience rather than a formal FDA indication for those conditions.

Why Neuro-Ophthalmology Reaches for Baclofen

Most patients meet baclofen as a spasticity drug. The neuro-ophthalmic story is different and much more targeted. When a patient describes the world appearing to drift or swing rhythmically and the examiner sees an eye movement that beats in one horizontal direction, pauses, and then reverses to beat the other way over a cycle of roughly one and a half to four minutes, the diagnosis is periodic alternating nystagmus (PAN). Acquired PAN is usually traced to dysfunction of the cerebellar nodulus and uvula, the structures that normally apply GABAergic braking to the brain's velocity-storage mechanism. When that inhibition is lost, the system swings back and forth without settling. Baclofen restores GABAergic tone and, in acquired PAN, often quiets the oscillation dramatically. It is one of the few situations in neuro-ophthalmology where a single oral drug, matched to the right mechanism, can produce a striking improvement.

How Baclofen Works

Baclofen is a structural analogue of the inhibitory neurotransmitter GABA, but it acts selectively at the GABA-B receptor rather than the GABA-A receptor that benzodiazepines target. Activating GABA-B receptors does two things: it reduces calcium entry into presynaptic nerve terminals, which dampens the release of excitatory neurotransmitters, and it increases potassium conductance in postsynaptic neurons, which hyperpolarizes them and makes them harder to fire. The net effect is reduced excitatory drive through spinal and brainstem circuits. In spasticity that translates to looser, less hyperactive muscles; in PAN it appears to reinstate the inhibitory control that keeps the eyes still.

Periodic Alternating Nystagmus: The Signature Use

PAN is easy to miss on a brief look because the direction reverses. A patient examined for only ten seconds may appear to have ordinary horizontal nystagmus; watched for two or three minutes, the telltale reversal emerges. Recognizing it matters, because PAN responds to baclofen far better than to most other agents, and because acquired PAN can be a clue to an underlying problem in the posterior fossa that deserves its own evaluation. Patients typically notice oscillopsia - the sense that the visual world is moving - along with blurred or unstable vision. When baclofen works, the oscillopsia eases and visual acuity often improves because the eyes hold steadier on what the person is trying to see.

Other Eye and Facial Uses

Beyond PAN, baclofen is sometimes tried in other forms of acquired nystagmus, including downbeat nystagmus, though the response there is less consistent and other strategies are often used first. It is occasionally added as an adjunct in blepharospasm and hemifacial spasm, where botulinum toxin injections remain the mainstay and baclofen plays at most a supporting role. It is also used broadly outside the eye for spasticity and for muscle-related pain. Congenital (infantile) nystagmus, by contrast, generally does not respond to baclofen the way acquired PAN does.

Dosing and Titration

The guiding principle is start low and go slow, because the dose that helps and the dose that causes drowsiness or weakness are often close together.

• Starting dose: commonly 5 mg two or three times daily
• Titration: increased in small steps (about 5 mg per dose) every few days as tolerated
• Typical maintenance: many patients settle around 10-20 mg three times daily; the labeled maximum for spasticity is commonly cited at 80 mg per day, though neuro-ophthalmic doses for nystagmus are frequently lower
• Kidney function matters: baclofen is cleared largely by the kidneys, so reduced kidney function can cause it to accumulate and produce confusion or excessive sedation; lower doses and slower titration are used in that setting

The goal is the lowest dose that steadies vision without leaving you sedated or weak. Finding it usually takes a few weeks of adjustment, and the benefit for nystagmus should be judged over that timeframe rather than after a single dose.

Oral Versus Intrathecal Baclofen

For severe spasticity that oral dosing cannot control, baclofen can be delivered directly into the cerebrospinal fluid through a surgically implanted intrathecal pump. This is a specialized treatment managed by spasticity and rehabilitation teams, not a neuro-ophthalmic one, but it is worth knowing about because intrathecal baclofen carries a distinct emergency: if the pump fails or the drug is interrupted abruptly, acute intrathecal baclofen withdrawal can develop, with high fever, severe rigidity, muscle breakdown, and, in extreme cases, life-threatening complications. Anyone with a baclofen pump should know the symptoms of pump malfunction and have a clear plan for urgent care.

Side Effects and Withdrawal

The most common effects relate to its sedative, muscle-relaxing action:

• Drowsiness and fatigue, especially early in treatment
• Dizziness and a sense of unsteadiness
• Muscle weakness or a "floppy" feeling if the dose is too high
• Nausea
• Confusion, more likely in older adults and in those with reduced kidney function

Pregnancy and Breastfeeding

Human data in pregnancy are limited. Baclofen crosses the placenta, and neonatal withdrawal (including seizures) has been reported in infants exposed late in pregnancy, particularly with intrathecal therapy. The decision to continue baclofen during pregnancy is individualized and should be made together with your obstetrician, weighing the benefit for your condition against the limited safety data. Baclofen passes into breast milk in small amounts; many clinicians consider breastfeeding compatible with monitoring of the infant for drowsiness or poor feeding, but this too should be discussed with your care team rather than decided alone.

Frequently Asked Questions

How will I know if baclofen is helping my nystagmus?

The clearest sign is steadier vision - less of the sense that the world is drifting or swinging, and sharper, more stable acuity when you try to read or look at a face. Because the dose is titrated upward over weeks, give it time before judging. Your doctor may also re-examine your eye movements to see whether the oscillation has lessened.

Is baclofen addictive?

Baclofen is not a drug people typically crave or misuse, but the body does become physically dependent on it with regular use. That is why it must be tapered rather than stopped suddenly. Physical dependence is not the same as addiction, but it does mean you should never run out of your supply.

Can I drink alcohol while taking it?

It is best to avoid or strictly limit alcohol. Both baclofen and alcohol depress the central nervous system, and together they can cause pronounced drowsiness, dizziness, and impaired coordination.

What happens if I run out or miss several doses?

Missing an occasional dose is usually minor, but going without baclofen for a sustained period after regular use risks the withdrawal syndrome described above. Refill early, keep a small buffer, and contact your prescriber promptly if you cannot get your medication.

Will baclofen fix the underlying cause of my nystagmus?

No. Baclofen treats the symptom by steadying the eyes; it does not repair the underlying brainstem or cerebellar process. That is why acquired periodic alternating nystagmus also warrants a search for an underlying cause, even when baclofen controls the movement well.